Biotin supplements may cause clinically significant interference for this test assay. If interference is suspected, it is strongly recomended that biotin is discontinued for at least one week prior to retesting
Samples should not be taken from patients receiving therapy with high biotin doses (i.e. > 5 mg/day) until at least 8 hours following the last biotin administration.
Fasting is recommended prior to specmen collection
Immediately following collection, thoroughly mix sample by gently inverting 5 times
Immediately following collection, mix sample thoroughly by gently inverting 8 - 10, times to prevent clotting
Frozen (preferred) - 1 month
Ambient - 4 hours
Refrigerated - 24 hours
Electrochemiluminescence immunoassay (ECLIA)
1.1 - 4.4 ng/mL